“…Several studies have investigated whether recipient or donor genotype at PNPLA3 or HSD17B13 loci was associated with acute rejection, incident diabetes, or recurrent liver disease after LT. 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 However, most studies included small, single-centre cohorts and reported conflicting findings. No previous study has examined the effect of donor genotype on post-LT survival.…”